|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$58,811.10 |
2.89% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$50,849.61 |
2.50% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$47,661.12 |
2.34% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,297.56 |
2.22% |
| Waters Corporation |
WAT |
941848103 |
120 |
$45,195.60 |
2.22% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$44,425.47 |
2.18% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$43,795.54 |
2.15% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,778.28 |
2.15% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$43,650.79 |
2.14% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$43,611.99 |
2.14% |
| Steris Plc |
STE |
G8473T100 |
169 |
$43,433.00 |
2.13% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,289.95 |
2.12% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$42,505.85 |
2.09% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$42,549.30 |
2.09% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$42,350.69 |
2.08% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,134.40 |
2.07% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$42,176.81 |
2.07% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$42,092.60 |
2.07% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$42,001.28 |
2.06% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$41,932.76 |
2.06% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$42,063.12 |
2.06% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$41,473.96 |
2.04% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$41,371.55 |
2.03% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$41,158.62 |
2.02% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$41,242.52 |
2.02% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$40,737.68 |
2.00% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$39,913.24 |
1.96% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$39,765.66 |
1.95% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$39,802.69 |
1.95% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$39,710.88 |
1.95% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$39,752.14 |
1.95% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$39,541.28 |
1.94% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$39,130.00 |
1.92% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,187.68 |
1.92% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$38,782.58 |
1.90% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$38,096.04 |
1.87% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$37,502.68 |
1.84% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$37,029.47 |
1.82% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$37,134.16 |
1.82% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$36,862.45 |
1.81% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$36,824.04 |
1.81% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$36,844.52 |
1.81% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$36,693.87 |
1.80% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$36,194.34 |
1.78% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$35,894.98 |
1.76% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$35,713.77 |
1.75% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$35,498.95 |
1.74% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$35,095.80 |
1.72% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$32,978.55 |
1.62% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$31,472.65 |
1.54% |
| US Dollar |
$USD |
|
2,198 |
$2,198.35 |
0.11% |
| Japanese Yen |
$JPY |
|
102,506 |
$659.04 |
0.03% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.14 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|